Acceptability of Vaccines Against Preventable Infections Including Coronavirus Disease 2019 Among Patients With Rheumatic Disease.
Acceptability of Vaccines Against Preventable Infections Including Coronavirus Disease 2019 Among Patients With Rheumatic Disease.
复制标题
DOI：
10.1002/acr2.11351
复制
发表时间：
2022-01
影响因子：
3.4
通讯作者：
Solomon DH
中科院分区：
文献类型：
--
作者：
Tedeschi SK;Ellrodt J;Stratton J;Santacroce L;Chandler PD;Gravallese EM;Solomon DH
广泛建议患有系统性风湿病的患者接种疫苗来预防可预防的感染。 2019 年冠状病毒病 (COVID-19) 大流行凸显了人们对疫苗接种态度的变化，特别是在使用新型疫苗平台方面。我们研究了系统性风湿病患者对 COVID-19 疫苗接种和其他可预防感染的态度，并将其与普通人群进行了比较。我们从 2020 年 12 月到 2021 年 4 月，使用安全的网络调查或英语或西班牙语纸质调查，对在布莱根妇女医院接受系统性风湿病治疗的患者进行了调查。我们纳入了全国哈里斯民意调查（2020 年 10 月和 2021 年 2 月）中使用的调查问题，以便将调查结果与普通人群的调查结果进行比较。使用描述性统计来估计和比较响应频率。 243 名参与者（回复率为 25%）中，平均年龄为 56 岁，其中 82% 是女性，33% 是非白人。类风湿性关节炎（50%）和系统性红斑狼疮（28%）是最常见的诊断。百分之三十之前曾因感染住院。 76% 的人非常或有些担心感染 COVID-19。对疫苗接种的态度非常积极，92% 的人在过去一年中接种过流感疫苗，84% 的人希望尽快接种 COVID-19 疫苗，而哈里斯民意调查受访者中这一比例为 30% 至 40%（P < 0.001）。医生建议接种疫苗和希望避免感染是希望接种疫苗的最常见原因。在学术医疗中心队列中发现的系统性风湿病患者群体中，对疫苗（包括对 COVID-19 疫苗）的接受度较高。医生的推荐是疫苗接种的关键因素。
Vaccination against preventable infections is widely recommended for patients with systemic rheumatic disease. The coronavirus disease 2019 (COVID‐19) pandemic has highlighted variability in attitudes toward vaccination, particularly with the use of novel vaccine platforms. We studied attitudes toward vaccination against COVID‐19 and other preventable infections among patients with systemic rheumatic disease and compared these against the general population. We surveyed patients treated at Brigham and Women’s Hospital for systemic rheumatic disease using a secure web‐based survey or paper survey in English or Spanish, from December 2020 to April 2021. We included survey questions used in the nationwide Harris Poll (October 2020 and February 2021), allowing the comparison of responses with those from the general population. Response frequencies were estimated and compared using descriptive statistics. Of 243 participants (25% response rate), the mean age was 56 years, 82% were women, and 33% were nonwhite. Rheumatoid arthritis (50%) and systemic lupus erythematosus (28%) were the most common diagnoses. Thirty percent had been hospitalized previously for any infection. Seventy‐six percent worried a lot or somewhat about contracting COVID‐19. Attitudes toward vaccination were very favorable, with 92% having received a flu shot in the past year and 84% desiring a COVID‐19 vaccine as soon as possible compared with 30% to 40% of Harris Poll respondents (P < 0.001). Physician recommendation to receive a vaccine and desire to avoid infection were the most common reasons for desiring vaccinations. Vaccine acceptability, including toward COVID‐19 vaccines, was high among this population of patients with systemic rheumatic disease seen at an academic medical center cohort. Physician recommendation is a key factor for vaccine uptake.
登录
查看更多内容
BNT162B2 mRNA COVID-19疫苗的安全性和功效。
DOI：
10.1056/nejmoa2034577
发表时间：
2020-12-31
期刊：
The New England journal of medicine
影响因子：
--
作者：
Polack FP;Thomas SJ;Kitchin N;Absalon J;Gurtman A;Lockhart S;Perez JL;Pérez Marc G;Moreira ED;Zerbini C;Bailey R;Swanson KA;Roychoudhury S;Koury K;Li P;Kalina WV;Cooper D;Frenck RW Jr;Hammitt LL;Türeci Ö;Nell H;Schaefer A;Ünal S;Tresnan DB;Mather S;Dormitzer PR;Şahin U;Jansen KU;Gruber WC;C4591001 Clinical Trial Group
通讯作者：
C4591001 Clinical Trial Group
DOI：
10.1056/nejmoa2035389
发表时间：
2021-02-04
期刊：
The New England journal of medicine
影响因子：
--
作者：
Baden LR;El Sahly HM;Essink B;Kotloff K;Frey S;Novak R;Diemert D;Spector SA;Rouphael N;Creech CB;McGettigan J;Khetan S;Segall N;Solis J;Brosz A;Fierro C;Schwartz H;Neuzil K;Corey L;Gilbert P;Janes H;Follmann D;Marovich M;Mascola J;Polakowski L;Ledgerwood J;Graham BS;Bennett H;Pajon R;Knightly C;Leav B;Deng W;Zhou H;Han S;Ivarsson M;Miller J;Zaks T;COVE Study Group
通讯作者：
COVE Study Group
影响因子：
4.7
作者：
Feldman, Candace H.;Xu, Chang;Costenbader, Karen H.
通讯作者：
Costenbader, Karen H.
影响因子：
13.3
作者：
Curtis, Jeffrey R.;Johnson, Sindhu R.;Mikuls, Ted R.
通讯作者：
Mikuls, Ted R.
DOI：
10.1016/s2665-9913(21)00039-4
发表时间：
2021-04
期刊：
The Lancet. Rheumatology
影响因子：
--
作者：
Felten R;Dubois M;Ugarte-Gil MF;Chaudier A;Kawka L;Bergier H;Costecalde C;Pijnenburg L;Fort J;Chatelus E;Sordet C;Javier RM;Gottenberg JE;Sibilia J;Fuentes-Silva Y;Arnaud L
通讯作者：
Arnaud L